Nassim Usman
Chief Executive Officer at Totus Medicines, Inc.
Net worth: 25 855 $ as of 30/05/2024
Network origin in Nassim Usman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA.
22
| Extinct | Miscellaneous Commercial Services | 22 |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA.
7
| Extinct | Medical Specialties | 7 |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY.
6
| Private Company | Financial Conglomerates | 6 |
Totus Medicines, Inc.
 Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Totus Medicines, Inc. manufactures drug products. The company is based in Cambridge, MA. The company was founded by Neil Dhawan, Jason Pontin. Neil Dhawan has been the CEO since incorporation.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nassim Usman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
| The University of Colorado | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Beijing Continent Pharmaceutical Co., Ltd.
 Beijing Continent Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Continent Pharmaceutical Co. Ltd. is a commercial-stage biopharmaceutical company committed to the research, development and commercialization of innovative drugs for organ fibrosis for two decades. The firm focuses on idiopathic pulmonary fibrosis (“IPF”) and have gradually broadened therapeutic field and research & development efforts to other areas of organ fibrosis. The company flagship product ETUARY (pirfenidone capsule) was approved in China in 2011 and is among the first three approved drugs for IPF worldwide. The firm has developed a pipeline of additional four innovative drug candidates, and amassed eight-years’ experience of successful commercialization. The company was founded in July 2002 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member President Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| Indiana University | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology GNI USA, Inc. engages in therapeutic pharmaceutical products development and production. The company was founded in 2001 and is headquartered in San Jose, CA. | Biotechnology | President Director of Finance/CFO Corporate Officer/Principal | |
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Comptroller/Controller/Auditor | |
| GNI GROUP LTD. | Biotechnology | Founder Director/Board Member Comptroller/Controller/Auditor | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Graduate Degree | |
Berkeley Advanced Biomaterials, Inc.
 Berkeley Advanced Biomaterials, Inc. Pharmaceuticals: MajorHealth Technology Berkeley Advanced Biomaterials, Inc. manufactures and distributes calcium-based products. Its products include HAP/TCP, nanocrystals, powder, granules and blocks. The company was incorporated by François Génin in October 1996 and is headquartered in Berkeley, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Pharmaceuticals: Major | Founder Director/Board Member | |
| GNI-EPS Pharmaceuticals, inc. | Chief Executive Officer Director/Board Member | ||
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
Shanghai GEP Pharmaceuticals, Inc.
 Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shanghai GEP Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
| The Colorado Bar Association | Corporate Officer/Principal Corporate Officer/Principal | ||
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Founder | |
| Cullgen Shanghai, Inc. | Chairman Director/Board Member | ||
| Sturm College of Law | College/University | Graduate Degree Graduate Degree | |
| University of Denver | College/University | Masters Business Admin Masters Business Admin | |
University of Connecticut Health Center
 University of Connecticut Health Center Other Consumer ServicesConsumer Services University of Connecticut Health Center provides healthcare services. It is an organization, which composed of the school of medicine, John Dempsey hospital, the UConn medical group & health partners, and university dentists. It offers services for cardiovascular, cancer, behavioral, ambulatory, and neonatal intensive-care. The company was founded in 1961 and is headquartered in Farmington, CT. | College/University | Doctorate Degree Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
LifeSci Index Partners LLC
 LifeSci Index Partners LLC Investment ManagersFinance LifeSci Index Partners LLC (LSIP) is an independent investment advisor headquartered in New York City. The firm was co-founded by Paul Yook, Andrew McDonald and Michael Rice in 2014. LSIP is an index provider of healthcare-based stock market indices and also serves as the investment sub-advisor for the BioShares exchange traded funds. | Investment Managers | Chief Executive Officer Founder | |
LifeSci Capital LLC
 LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013. | Investment Banks/Brokers | Chief Executive Officer Founder | |
| VINCERX PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| University of California, Irvine | College/University | Doctorate Degree Doctorate Degree | |
LifeSci Advisors LLC
 LifeSci Advisors LLC Miscellaneous Commercial ServicesCommercial Services LifeSci Advisors LLC is an investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. Their services are designed to increase clients? visibility within the investment community and to educate investors about the opportunity. | Miscellaneous Commercial Services | Founder Founder | |
| LifeSci Partners | Chief Executive Officer Founder | ||
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Consultant / Advisor | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal |
Statistics
International
| United States | 40 |
| China | 7 |
| Japan | 2 |
| Hong Kong | 2 |
| Singapore | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 344 |
| Corporate Officer/Principal | 117 |
| Independent Dir/Board Member | 65 |
| Chairman | 63 |
| Founder | 52 |
Most connected contacts
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Bryan Roberts | 44 |
| Augustine Lawlor | 43 |
| Michael Rice | 33 |
| Asish Xavier | 33 |
| Jeff Himawan | 24 |
| Bharatt Chowrira | 24 |
| Harold Selick | 24 |
| Chris Christoffersen | 24 |
| R. Greer | 23 |
| Shaan Gandhi | 22 |
| Martin Schmieg | 20 |
| Andrew McDonald | 19 |
| Thomas Eastling | 17 |
| Ying Luo | 17 |
- Stock Market
- Insiders
- Nassim Usman
- Company connections